Company intelligence / Profile preview

AirWare Labs

Scottsdale, Arizona, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

AirWare Labs sells patented nasal intranasal inserts and filters, with some lines infused with essential oils, designed to increase airflow, filter allergens and pathogens, and provide relief for conditions like allergies, sleep disturbances and travel illnesses. The products are commercially available at major retailers and expanding globally, but there is no evidence of formal clinical trials published in peer-reviewed scientific journals as of October 2025.

Therapeutic areas: ImmunologyNeurologyInfectious DiseasesPulmonologyGastroenterologyPsychiatry
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Quest Products Inc.

Beyond the preview

Go deeper on AirWare Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AirWare Labs.

Explore the full profile